Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1236 in adult patients with cystic fibrosis
NCT00812045Phase 2Withdrawn
- Sponsor
- AstraZeneca
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of AZD1236 in cystic fibrosis (CF), sponsored by AstraZeneca. Planned start Dec 2009; status: withdrawn.
02
Drugs
AZD1236
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00812045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812045.